Remote smoking cessation in Derbyshire absorbed the first pandemic shock
When Live Life Better Derbyshire moved from face-to-face support to remote-only smoking cessation care on 19 March 2020, the service entered a test of continuity rather than a clinical experiment. The abrupt switch happened during a period when early pandemic data were widely circulating about the higher risk of severe COVID-19 outcomes among people who smoked. In public health terms, that could have driven more people toward quitting. It also could have disrupted access, especially for residents who depended on in-person support, walk-in contact, or the routine structure of clinic-based cessation care.
An interrupted time series analysis spanning 1 January 2018 through 31 December 2021 offers a clear picture of what happened next. Across that four-year window, 11,393 episodes of smoking cessation support were opened. The service did not collapse under the change in delivery model. Instead, it showed a short-term fall in activity, followed by stability in the core outcomes that matter most: quit date setting and 4-week self-reported abstinence.
One immediate effect stood out. Episode openings fell by 20% at the point of transition to remote-only delivery, with an incidence rate ratio of 0.88 and a 95% confidence interval of 0.646 to 0.992. In practical terms, fewer smokers entered the service right away, even as the broader pandemic created new urgency around tobacco cessation.
Access fell first, but cessation momentum persisted
The weekly counts for all measured outcomes were rising before the switch to remote delivery. That pre-pandemic upward trajectory matters, because it shows the service was already gaining use before COVID-19 rewrote the rules of outpatient contact. The interruption changed the level of activity, but not the underlying direction of the service over time.
No change was seen in the number of quit dates set. No change was seen in the number of 4-week quits. The longer-term trends also held steady after the conversion to remote support. Those findings point to a service that lost some initial reach at the point of transition, then recovered enough functional capacity to preserve its core cessation work.
Remote delivery appears to have been able to support the behavioral steps that drive quitting: agreeing on a date, initiating the quit attempt, and maintaining engagement long enough to report abstinence at follow-up. For smoking cessation, those steps are tightly linked. A quit date is not a bureaucratic marker; it is the moment when motivation becomes an actionable plan, often reinforced by counseling, follow-up, and pharmacotherapy support. If remote delivery were substantially weaker than in-person care, the first place to expect deterioration would be in these transition points. It did not happen here.
The service redesign altered contact patterns more than quit outcomes
The most plausible explanation for the immediate reduction in episodes opened is not diminished need, but reduced access friction and changed help-seeking behavior during the first phase of the pandemic. Many routine healthcare interactions were disrupted, and people were balancing infection fears, lockdown rules, work changes, and household pressures. Smoking cessation services were not isolated from that context. A move from face-to-face to remote care can lower barriers for some patients, while removing the direct personal contact that encourages others to enroll.
For a lifestyle service embedded in community care, the first pandemic weeks likely changed the profile of who could and would seek help. Telephone or remote support can widen access for patients with transport barriers, time constraints, or mobility problems. It can also disadvantage people who rely on drop-in attendance, informal prompting, or in-person reassurance to begin treatment. The Derbyshire data suggest both effects may have been present, but the net clinical outcome was modest rather than disruptive.
The absence of a sustained reduction in quit dates or 4-week quits is clinically important. Smoking cessation services are often judged by reach, engagement, and abstinence. Reach dropped briefly. Engagement and short-term success did not show the same decline. In a service context, that means the care model preserved enough therapeutic function to keep supporting quit attempts even after its delivery format changed completely.
What the interrupted time series can and cannot say
Interrupted time series analysis is well suited to this kind of policy and service transition because it separates an immediate level change from a shift in trend over time. Here, the pandemic-era switch to remote delivery produced a visible short-term decline in episode openings, but no measurable deterioration in quit-date setting or reported 4-week quitting, and no long-term downward slope after the change. That design cannot prove causation in a biological sense, yet it does provide a strong real-world view of how a service behaved under stress.
The outcome definition also matters. Self-reported quit at 4 weeks is a standard service measure, but it is not the same as biochemically verified long-term abstinence. The analysis therefore speaks most directly to service activity and near-term cessation success, not to sustained nicotine abstinence months later. Even so, short-term quit measures are the operational currency of many smoking cessation programs, and they are often the first sign that a model of care remains workable.
The data also come from a single integrated lifestyle service in Derbyshire. Local service design, staffing, patient population, and digital readiness could all influence how well remote support performs. A different region might not reproduce the same pattern. Still, the main signal is difficult to ignore: the pandemic and the shift to remote delivery did not produce a major sustained collapse in cessation activity or early quit success.
A service model that held together under pressure
The Derbyshire experience argues for a restrained reading of pandemic disruption in smoking cessation care. Remote delivery did not fully replace the lost face-to-face entry pathway, because episode openings dipped at the moment of change. Yet the essential clinical sequence survived. Smokers still set quit dates. Some still reported quitting at 4 weeks. The service’s longer-term trajectory did not deteriorate.
For commissioners and frontline teams, the finding is less about celebrating remote care than about preserving flexibility. Smoking cessation support can remain effective when face-to-face contact is not possible, provided the service maintains enough structure to keep patients engaged after referral. The biggest vulnerability may lie at the front door, where access patterns shift quickly when people are asked to move from a familiar clinic encounter to a remote model overnight.
This analysis leaves one practical question unanswered: which elements of remote delivery preserved cessation success, and which groups were least likely to enter care after the switch? Those details would matter for future service design, especially if another large-scale disruption forces the same system to move away from in-person support again.